Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools.

Recent advancements in pancreatic cancer prognosis have led to the development of the Tianjin Grading System, a tool ...

Discover 10 AI-proof healthcare careers that will remain secure as AI transforms helathcare, including roles that rely on ...

Denmark: A new nationwide study published in JAMA Surgery has identified an optimal mesh weight range that may significantly ...

Women with eczema or other atopic skin conditions may face greater risks of implant-related problems after breast ...

Click here to read the Cover Story, “GLP-1s may have profound impact on total joint replacement.”GLP-1 receptor agonists mimic the action of endogenous GLP-1, a hormone that stimulates insulin ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence ...

Anesthesiology saw a year of significant innovation in 2025 as new technologies, techniques and care models redefined what is possible in the perioperative environment. From AI-driven automation to ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of two abstracts at the North America Conference on Lung Cancer (NACLC) in ...

AIIMS Jammu organized a comprehensive CME-cum-simulation workshop on Obstetric Anaesthesia centred on the theme “Preventing ...

New trials highlight Pathlight’s performance in the neoadjuvant triple-negative breast cancer (TNBC) settingMORRISVILLE, N.C.--(BUSINESS WIRE)--#BreastCancer--SAGA Diagnostics®, a pioneer in ...

(Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients ...